Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
NCT02513654Phase 1Completed
- Sponsor
- GSK
- Start
- Sep 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lamotrigine in bipolar disorder (BD), sponsored by GSK. Primary endpoints: Area Under the Concentration-Time Curve (0-tau), Maximum Observed Plasma Concentration and 1 more. Started Sep 2015; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02513654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513654.